FULVESTRANT EVER PHARMA 250 MG is indicated for the treatment of oestrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:* not previously treated with endocrine therapy,or* with disease relapse on or after adjuvant endocrine therapy,or* disease progression on endocrine therapy.Combination Therapy with Palbociclib: FULVESTRANT EVER PHARMA 250 MG is indicated for the treatment of HR-positive, human epidermal growth factor receptor 2 (HER2)- negative advanced or metastatic breast cancer in combination with palbociclib in women with disease progression after endocrine therapy.